{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:32:38Z","timestamp":1790109158499,"version":"4.0.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11102-024-01469-x","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T14:41:25Z","timestamp":1731595285000},"page":"802-812","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Modern approach to bone comorbidity in prolactinoma"],"prefix":"10.1007","volume":"27","author":[{"given":"Meliha Melin","family":"Uygur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Menotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"issue":"1","key":"1469_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ecl.2014.10.014","volume":"44","author":"G Mazziotti","year":"2015","unstructured":"Mazziotti G, Chiavistelli S, Giustina A (2015) Pituitary diseases and bone. Endocrinol Metab Clin North Am 44(1):171\u2013180 Epub 20141104. https:\/\/doi.org\/10.1016\/j.ecl.2014.10.014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1469_CR2","doi-asserted-by":"publisher","unstructured":"Mazziotti G, Frara S, Giustina A (2018) Pituitary Diseases and Bone. Endocr Rev.;39(4):440\u2013\u200988. https:\/\/doi.org\/10.1210\/er.2018-00005. PubMed PMID: 29684108","DOI":"10.1210\/er.2018-00005"},{"issue":"4","key":"1469_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tem.2023.01.006","volume":"34","author":"MM Uygur","year":"2023","unstructured":"Uygur MM, Frara S, di Filippo L, Giustina A (2023) New tools for bone health assessment in secreting pituitary adenomas. Trends Endocrinol Metab 34(4):231\u2013242 Epub 2023\/03\/04. https:\/\/doi.org\/10.1016\/j.tem.2023.01.006","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1469_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ecl.2007.10.013","volume":"37","author":"T Mancini","year":"2008","unstructured":"Mancini T, Casanueva FF, Giustina A (2008) Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am 37(1):67\u201399 viii. Epub 2008\/01\/30. https:\/\/doi.org\/10.1016\/j.ecl.2007.10.013","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1469_CR5","doi-asserted-by":"publisher","unstructured":"Petersenn S, Giustina A (2020) Diagnosis and management of prolactinomas: current challenges. Pituitary.;23(1):1\u20132. https:\/\/doi.org\/10.1007\/s11102-019-01025-y. PubMed PMID: 31900881","DOI":"10.1007\/s11102-019-01025-y"},{"issue":"6","key":"1469_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G et al (2022) Clinical Biology of the Pituitary Adenoma. Endocr Rev 43(6):1003\u20131037. https:\/\/doi.org\/10.1210\/endrev\/bnac010PubMed PMID: 35395078; PubMed Central PMCID: PMCPMC9695123","journal-title":"Endocr Rev"},{"issue":"3","key":"1469_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11102-024-01392-1","volume":"27","author":"M Castle-Kirszbaum","year":"2024","unstructured":"Castle-Kirszbaum M, Biermasz N, Kam J, Goldschlager T (2024) Quality of life in Prolactinoma: a systematic review. Pituitary 27(3):239\u2013247 Epub 20240424. https:\/\/doi.org\/10.1007\/s11102-024-01392-1","journal-title":"Pituitary"},{"issue":"1","key":"1469_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/21556660.2019.1677674","volume":"8","author":"T Gold","year":"2019","unstructured":"Gold T, Williams SA, Weiss RJ, Wang Y, Watkins C, Carroll J et al (2019) Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey. J Drug Assess 8(1):175\u2013183 PubMed PMID: 31692954; PubMed Central PMCID: PMCPMC6818103","journal-title":"J Drug Assess"},{"issue":"12","key":"1469_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Reviews Endocrinol 19(12):722\u2013740. https:\/\/doi.org\/10.1038\/s41574-023-00886-5","journal-title":"Nat Reviews Endocrinol"},{"key":"1469_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A et al (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal Osteoporosis\u20142020 Update. Endocr Pract 26:1\u201346. https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL","journal-title":"Endocr Pract"},{"key":"1469_CR11","doi-asserted-by":"publisher","unstructured":"Colao A, Di Somma C, Loche S, Di Sarno A, Klain M, Pivonello R et al (2000) Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clin Endocrinol (Oxf).;52(3):319\u2013\u200927. https:\/\/doi.org\/10.1046\/j.1365-2265.2000.00902.x. PubMed PMID: 10718830","DOI":"10.1046\/j.1365-2265.2000.00902.x"},{"issue":"5","key":"1469_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/jama.1984.03340290040017","volume":"251","author":"CE Cann","year":"1984","unstructured":"Cann CE, Martin MC, Genant HK, Jaffe RB (1984) Decreased spinal mineral content in amenorrheic women. JAMA 251(5):626\u2013629 PubMed PMID: 6690836","journal-title":"JAMA"},{"issue":"5","key":"1469_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1210\/jcem-64-5-1021","volume":"64","author":"J Schlechte","year":"1987","unstructured":"Schlechte J, el-Khoury G, Kathol M, Walkner L (1987) Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 64(5):1021\u20131026. https:\/\/doi.org\/10.1210\/jcem-64-5-1021PubMed PMID: 3558723","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1469_CR14","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1210\/jcem-59-6-1050","volume":"59","author":"MC Koppelman","year":"1984","unstructured":"Koppelman MC, Kurtz DW, Morrish KA, Bou E, Susser JK, Shapiro JR et al (1984) Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab 59(6):1050\u20131053. https:\/\/doi.org\/10.1210\/jcem-59-6-1050PubMed PMID: 6490793","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1469_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11102-011-0293-4","volume":"14","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Mancini T, Mormando M, De Menis E, Bianchi A, Doga M et al (2011) High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary 14(4):299\u2013306. https:\/\/doi.org\/10.1007\/s11102-011-0293-4PubMed PMID: 21301967","journal-title":"Pituitary"},{"issue":"1","key":"1469_CR16","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1038\/s41598-021-84606-x","volume":"11","author":"L Andereggen","year":"2021","unstructured":"Andereggen L, Frey J, Andres RH, Luedi MM, Widmer HR, Beck J et al (2021) Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas. Sci Rep 11(1):5122 Epub 20210304. https:\/\/doi.org\/10.1038\/s41598-021-84606-x","journal-title":"Sci Rep"},{"issue":"3","key":"1469_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12020-011-9462-5","volume":"39","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Porcelli T, Mormando M, De Menis E, Bianchi A, Mejia C et al (2011) Vertebral fractures in males with prolactinoma. Endocrine 39(3):288\u2013293","journal-title":"Endocrine"},{"issue":"7","key":"1469_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.7326\/0003-4819-110-7-526","volume":"110","author":"SL Greenspan","year":"1989","unstructured":"Greenspan SL, Oppenheim DS, Klibanski A (1989) Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110(7):526\u2013531","journal-title":"Ann Intern Med"},{"issue":"26","key":"1469_CR19","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJM198012253032605","volume":"303","author":"A Klibanski","year":"1980","unstructured":"Klibanski A, Neer RM, Beitins IZ, Ridgway EC, Zervas NT, McARTHUR JW (1980) Decreased bone density in hyperprolactinemic women. N Engl J Med 303(26):1511\u20131514","journal-title":"N Engl J Med"},{"issue":"6","key":"1469_CR20","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1210\/jcem-56-6-1120","volume":"56","author":"JA Schlechte","year":"1983","unstructured":"Schlechte JA, Sherman B, Martin R (1983) Bone density in amenorrheic women with and without hyperprolactinemia. J Clin Endocrinol Metab 56(6):1120\u20131123. https:\/\/doi.org\/10.1210\/jcem-56-6-1120PubMed PMID: 6404918","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1469_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jcb.22161","volume":"107","author":"D Seriwatanachai","year":"2009","unstructured":"Seriwatanachai D, Krishnamra N, Van Leeuwen J (2009) Evidence for direct effects of prolactin on human osteoblasts: inhibition of cell growth and mineralization. J Cell Biochem 107(4):677\u2013685","journal-title":"J Cell Biochem"},{"issue":"9","key":"1469_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJM198608283150903","volume":"315","author":"A Klibanski","year":"1986","unstructured":"Klibanski A, Greenspan SL (1986) Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med 315(9):542\u2013546","journal-title":"N Engl J Med"},{"key":"1469_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.wneu.2016.10.059","volume":"97","author":"L Andereggen","year":"2017","unstructured":"Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW et al (2017) Long-term Follow-Up of Primary Medical Versus Surgical treatment of Prolactinomas in men: effects on Hyperprolactinemia, Hypogonadism, and Bone Health. World Neurosurg 97:595\u2013602 Epub 20161020. https:\/\/doi.org\/10.1016\/j.wneu.2016.10.059","journal-title":"World Neurosurg"},{"key":"1469_CR24","doi-asserted-by":"publisher","first-page":"1338345","DOI":"10.3389\/fendo.2024.1338345","volume":"15","author":"L Dzialach","year":"2024","unstructured":"Dzialach L, Sobolewska J, Zak Z, Respondek W, Witek P (2024) Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment. Front Endocrinol (Lausanne) 15:1338345 Epub 20240202. https:\/\/doi.org\/10.3389\/fendo.2024.1338345","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1469_CR25","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/eje-21-0977","volume":"186","author":"R Cozzi","year":"2022","unstructured":"Cozzi R, Ambrosio MR, Attanasio R, Battista C, Bozzao A, Caputo M et al (2022) Italian Association of Clinical Endocrinologists (AME) and international chapter of clinical endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors. Eur J Endocrinol 186(3):P1\u2013p33 Epub 20220203. https:\/\/doi.org\/10.1530\/eje-21-0977","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1469_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/s2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875 Epub 20211020. https:\/\/doi.org\/10.1016\/s2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1469_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000494725","volume":"109","author":"S Peki\u0107","year":"2019","unstructured":"Peki\u0107 S, Medic Stojanoska M, Popovic V (2019) Hyperprolactinemia\/Prolactinomas in the postmenopausal period: challenges in diagnosis and management. Neuroendocrinology 109(1):28\u201333 Epub 2018\/10\/23. doi: 10.1159\/000494725. PubMed PMID: 30347396","journal-title":"Neuroendocrinology"},{"issue":"5","key":"1469_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","volume":"20","author":"FF Casanueva","year":"2017","unstructured":"Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS et al (2017) Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): a Pituitary Society Statement. Pituitary 20(5):489\u2013498. https:\/\/doi.org\/10.1007\/s11102-017-0838-2PubMed PMID: 28884415; PubMed Central PMCID: PMCPMC5606938","journal-title":"Pituitary"},{"issue":"3","key":"1469_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ecl.2020.05.010","volume":"49","author":"S Frara","year":"2020","unstructured":"Frara S, Rodriguez-Carnero G, Formenti AM, Martinez-Olmos MA, Giustina A, Casanueva FF (2020) Pituitary Tumors Centers of Excellence. Endocrinol Metab Clin North Am 49(3):553\u2013564 Epub 20200715. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1469_CR30","doi-asserted-by":"publisher","unstructured":"Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P et al Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Pituitary. 2024. Epub 20240604. https:\/\/doi.org\/10.1007\/s11102-024-01397-w. PubMed PMID: 38833044","DOI":"10.1007\/s11102-024-01397-w"},{"issue":"5","key":"1469_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11102-023-01345-0","volume":"26","author":"A Giustina","year":"2023","unstructured":"Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P et al (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26(5):583\u2013596 Epub 20230828. https:\/\/doi.org\/10.1007\/s11102-023-01345-0","journal-title":"Pituitary"},{"issue":"5","key":"1469_CR32","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s11102-022-01264-6","volume":"25","author":"M Couselo","year":"2022","unstructured":"Couselo M, Frara S, Giustina A, Casanueva FF (2022) Pituitary tumor centers of excellence for Cushing\u2019s disease. Pituitary 25(5):772\u2013775 Epub 20220910. doi: 10.1007\/s11102-022-01264-6. PubMed PMID: 36087228; PubMed Central PMCID: PMCPMC9587956","journal-title":"Pituitary"},{"key":"1469_CR33","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2022.1573","author":"SM Kim","year":"2022","unstructured":"Kim SM, Sultana F, Korkmaz F, Lizneva D, Yuen T, Zaidi M (2022) Independent skeletal actions of Pituitary hormones. Endocrinol Metab (Seoul). Epub 2022\/09\/29 https:\/\/doi.org\/10.3803\/EnM.2022.1573","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"12","key":"1469_CR34","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41574-023-00894-5","volume":"19","author":"M Zaidi","year":"2023","unstructured":"Zaidi M, Yuen T, Kim SM (2023) Pituitary crosstalk with bone, adipose tissue and brain. Nat Rev Endocrinol 19(12):708\u2013721 Epub 20230915. https:\/\/doi.org\/10.1038\/s41574-023-00894-5","journal-title":"Nat Rev Endocrinol"},{"key":"1469_CR35","doi-asserted-by":"publisher","unstructured":"Kim SM, Sultana F, Korkmaz F, Rojekar S, Pallapati A, Ryu V et al Neuroendocrinology of bone. Pituitary. 2024. Epub 20240803. https:\/\/doi.org\/10.1007\/s11102-024-01437-5. PubMed PMID: 39096452","DOI":"10.1007\/s11102-024-01437-5"},{"issue":"6","key":"1469_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1210\/endrev\/bnab015","volume":"42","author":"EG Mills","year":"2021","unstructured":"Mills EG, Yang L, Nielsen MF, Kassem M, Dhillo WS, Comninos AN (2021) The Relationship between Bone and Reproductive hormones Beyond estrogens and androgens. Endocr Rev 42(6):691\u2013719. https:\/\/doi.org\/10.1210\/endrev\/bnab015PubMed PMID: 33901271; PubMed Central PMCID: PMCPMC8599211","journal-title":"Endocr Rev"},{"issue":"1","key":"1469_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1210\/endo.140.1.6436","volume":"140","author":"P Cl\u00e9ment-Lacroix","year":"1999","unstructured":"Cl\u00e9ment-Lacroix P, Ormandy C, Lepescheux L, Ammann P, Damotte D, Goffin V et al (1999) Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology 140(1):96\u2013105 PubMed PMID: 9886812","journal-title":"Endocrinology"},{"issue":"6","key":"1469_CR38","doi-asserted-by":"publisher","first-page":"E1216","DOI":"10.1152\/ajpendo.2000.279.6.E1216","volume":"279","author":"D Coss","year":"2000","unstructured":"Coss D, Yang L, Kuo CB, Xu X, Luben RA, Walker AM (2000) Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat. Am J Physiology-Endocrinology Metabolism 279(6):E1216\u2013E25","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"1","key":"1469_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/bbrc.1996.1800","volume":"229","author":"N Bataille-Simoneau","year":"1996","unstructured":"Bataille-Simoneau N, Gerland K, Chappard D, Basle MF, Mercier L (1996) Expression of prolactin receptors in human osteosarcoma cells. Biochem Biophys Res Commun 229(1):323\u2013328. https:\/\/doi.org\/10.1006\/bbrc.1996.1800PubMed PMID: 8954126","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1469_CR40","doi-asserted-by":"publisher","first-page":"E443","DOI":"10.1152\/ajpendo.00333.2006","volume":"292","author":"N Charoenphandhu","year":"2007","unstructured":"Charoenphandhu N, Tudpor K, Thongchote K, Saengamnart W, Puntheeranurak S, Krishnamra N (2007) High-calcium diet modulates effects of long-term prolactin exposure on the cortical bone calcium content in ovariectomized rats. Am J Physiology-Endocrinology Metabolism 292(2):E443\u2013E52","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"1","key":"1469_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12576-009-0059-1","volume":"60","author":"P Suntornsaratoon","year":"2010","unstructured":"Suntornsaratoon P, Wongdee K, Krishnamra N, Charoenphandhu N (2010) Femoral bone mineral density and bone mineral content in bromocriptine-treated pregnant and lactating rats. J Physiol Sci 60(1):1\u20138 Epub 20090917. https:\/\/doi.org\/10.1007\/s12576-009-0059-1","journal-title":"J Physiol Sci"},{"issue":"3","key":"1469_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.bone.2007.11.008","volume":"42","author":"D Seriwatanachai","year":"2008","unstructured":"Seriwatanachai D, Thongchote K, Charoenphandhu N, Pandaranandaka J, Tudpor K, Teerapornpuntakit J et al (2008) Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand\/osteoprotegerin ratio. Bone 42(3):535\u2013546 PubMed PMID: 18166509","journal-title":"Bone"},{"key":"1469_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11010-010-0674-4","volume":"349","author":"K Wongdee","year":"2011","unstructured":"Wongdee K, Tulalamba W, Thongbunchoo J, Krishnamra N, Charoenphandhu N (2011) Prolactin alters the mRNA expression of osteoblast-derived osteoclastogenic factors in osteoblast-like UMR106 cells. Mol Cell Biochem 349:195\u2013204","journal-title":"Mol Cell Biochem"},{"key":"1469_CR44","doi-asserted-by":"publisher","unstructured":"Yun SJ, Sang H, Park SY, Chin SO (2024) Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia\/Osteoporosis. Int J Mol Sci.;25(3). Epub 20240125. https:\/\/doi.org\/10.3390\/ijms25031474. PubMed PMID: 38338751; PubMed Central PMCID: PMCPMC10855748","DOI":"10.3390\/ijms25031474"},{"issue":"3","key":"1469_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11102-020-01041-3","volume":"23","author":"L di Filippo","year":"2020","unstructured":"di Filippo L, Doga M, Resmini E, Giustina A (2020) Hyperprolactinemia and bone. Pituitary 23(3):314\u2013321","journal-title":"Pituitary"},{"issue":"1","key":"1469_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1210\/jcem.80.1.7829600","volume":"80","author":"A Giustina","year":"1995","unstructured":"Giustina A, Bussi AR, Jacobello C, Wehrenberg WB (1995) Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J Clin Endocrinol Metab 80(1):122\u2013129. https:\/\/doi.org\/10.1210\/jcem.80.1.7829600PubMed PMID: 7829600","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1469_CR47","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1210\/jcem.83.3.4674","volume":"83","author":"C Di Somma","year":"1998","unstructured":"Di Somma C, Colao A, Di Sarno A, Klain M, Landi ML, Facciolli G et al (1998) Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. J Clin Endocrinol Metabolism 83(3):807\u2013813","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"1469_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11102-007-0064-4","volume":"11","author":"EC de Oliveira Naliato","year":"2008","unstructured":"de Oliveira Naliato EC, Violante AHD, Caldas D, Farias MLF, Bussade I, Lamounier Filho A et al (2008) Bone density in women with prolactinoma treated with dopamine agonists. Pituitary 11(1):21\u201328","journal-title":"Pituitary"},{"issue":"3","key":"1469_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s12020-021-02751-9","volume":"73","author":"MM Uygur","year":"2021","unstructured":"Uygur MM, Yaz\u0131c\u0131 DD, Bu\u011fdayc\u0131 O, Yavuz DG (2021) Prevalence of vertebral fractures and serum sclerostin levels in acromegaly. Endocrine 73(3):667\u2013673. https:\/\/doi.org\/10.1007\/s12020-021-02751-9","journal-title":"Endocrine"},{"issue":"9","key":"1469_CR50","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1210\/clinem\/dgab260","volume":"106","author":"PPB Silva","year":"2021","unstructured":"Silva PPB, Pereira RMR, Takayama L, Borba CG, Duarte FH, Trarbach EB et al (2021) Impaired bone microarchitecture in Premenopausal Women with Acromegaly: the possible role of wnt signaling. J Clin Endocrinol Metab 106(9):2690\u20132706. https:\/\/doi.org\/10.1210\/clinem\/dgab260PubMed PMID: 33871626","journal-title":"J Clin Endocrinol Metab"},{"key":"1469_CR51","doi-asserted-by":"publisher","unstructured":"Belaya ZE, Rozhinskaya LY, Melnichenko GA, Solodovnikov AG, Dragunova NV, Iljin AV et al (2013) Serum extracellular secreted antagonists of the canonical Wnt\/\u03b2-catenin signaling pathway in patients with Cushing\u2019s syndrome. Osteoporos Int.;24(8):2191-9. Epub 20130129. https:\/\/doi.org\/10.1007\/s00198-013-2268-y. PubMed PMID: 23358608","DOI":"10.1007\/s00198-013-2268-y"},{"issue":"6","key":"1469_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/0003-4819-104-6-777","volume":"104","author":"SL Greenspan","year":"1986","unstructured":"Greenspan SL, Neer RM, Ridgway EC, Klibanski A (1986) Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 104(6):777\u2013782. https:\/\/doi.org\/10.7326\/0003-4819-104-6-777PubMed PMID: 3706929","journal-title":"Ann Intern Med"},{"issue":"1","key":"1469_CR53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1210\/jcem-67-1-124","volume":"67","author":"A Klibanski","year":"1988","unstructured":"Klibanski A, Biller BM, Rosenthal DI, Schoenfeld DA, Saxe V (1988) Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab 67(1):124\u2013130. https:\/\/doi.org\/10.1210\/jcem-67-1-124PubMed PMID: 3379129","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1469_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/bf03345523","volume":"28","author":"EC Naliato","year":"2005","unstructured":"Naliato EC, Farias ML, Braucks GR, Costa FS, Zylberberg D, Violante AH (2005) Prevalence of osteopenia in men with prolactinoma. J Endocrinol Invest 28(1):12\u201317. https:\/\/doi.org\/10.1007\/bf03345523PubMed PMID: 15816365","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1469_CR55","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.bone.2009.06.006","volume":"45","author":"T Mancini","year":"2009","unstructured":"Mancini T, Mazziotti G, Doga M, Carpinteri R, Simetovic N, Vescovi PP et al (2009) Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone 45(4):784\u2013788 Epub 20090613. https:\/\/doi.org\/10.1016\/j.bone.2009.06.006","journal-title":"Bone"},{"issue":"2","key":"1469_CR56","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.1210\/clinem\/dgaa738","volume":"106","author":"L di Filippo","year":"2021","unstructured":"di Filippo L, Formenti AM, Doga M, Pedone E, Rovere-Querini P, Giustina A (2021) Radiological thoracic vertebral fractures are highly prevalent in COVID-19 and predict Disease outcomes. J Clin Endocrinol Metab 106(2):e602\u2013e14. https:\/\/doi.org\/10.1210\/clinem\/dgaa738PubMed PMID: 33159451; PubMed Central PMCID: PMCPMC7797741","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1469_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11102-007-0064-4","volume":"11","author":"EC Naliato","year":"2008","unstructured":"Naliato EC, Violante AH, Caldas D, Farias ML, Bussade I, Lamounier Filho A et al (2008) Bone density in women with prolactinoma treated with dopamine agonists. Pituitary 11(1):21\u201328. https:\/\/doi.org\/10.1007\/s11102-007-0064-4PubMed PMID: 17661178","journal-title":"Pituitary"},{"key":"1469_CR58","doi-asserted-by":"publisher","unstructured":"Vestergaard P, J\u00f8rgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L et al (2002) Fracture risk is increased in patients with GH deficiency or untreated prolactinomas\u2013a case-control study. Clin Endocrinol (Oxf).;56(2):159\u2013\u200967. https:\/\/doi.org\/10.1046\/j.0300-0664.2001.01464.x. PubMed PMID: 11874406","DOI":"10.1046\/j.0300-0664.2001.01464.x"},{"key":"1469_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.maturitas.2021.06.014","volume":"151","author":"RS Auriemma","year":"2021","unstructured":"Auriemma RS, Pirchio R, Pivonello R, Colao A (2021) Hyperprolactinemia after menopause: diagnosis and management. Maturitas 151:36\u201340 Epub 2021\/08\/28. https:\/\/doi.org\/10.1016\/j.maturitas.2021.06.014","journal-title":"Maturitas"},{"issue":"2","key":"1469_CR60","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine Society clinical practice guideline. J Clin Endocrinol Metabolism 96(2):273\u2013288","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"5","key":"1469_CR61","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/er.2007-0036","volume":"29","author":"A Giustina","year":"2008","unstructured":"Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29(5):535\u2013559 Epub 20080424. doi: 10.1210\/er.2007-0036. PubMed PMID: 18436706; PubMed Central PMCID: PMCPMC2726838","journal-title":"Endocr Rev"},{"issue":"6","key":"1469_CR62","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1530\/eje-14-0097","volume":"170","author":"G Mazziotti","year":"2014","unstructured":"Mazziotti G, Mormando M, Cristiano A, Bianchi A, Porcelli T, Giampietro A et al (2014) Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism. Eur J Endocrinol 170(6):893\u2013899. https:\/\/doi.org\/10.1530\/eje-14-0097PubMed PMID: 24836549","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1469_CR63","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00198-021-06289-4","volume":"33","author":"L Wang","year":"2022","unstructured":"Wang L, Chen K, Duan L, Ke X, Gong F, Pan H et al (2022) Bone microarchitecture impairment in prolactinoma patients assessed by HR-pQCT. Osteoporos Int 33(7):1535\u20131544 Epub 2022\/02\/23. https:\/\/doi.org\/10.1007\/s00198-021-06289-4","journal-title":"Osteoporos Int"},{"issue":"6","key":"1469_CR64","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/bf02554932","volume":"37","author":"MP Caraceni","year":"1985","unstructured":"Caraceni MP, Corghi E, Ortolani S, Casazza S, D\u2019Alberton A, Motta T (1985) Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia. Calcif Tissue Int 37(6):687\u2013689. https:\/\/doi.org\/10.1007\/bf02554932PubMed PMID: 3937596","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1469_CR65","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1210\/jcem.75.3.1517356","volume":"75","author":"BM Biller","year":"1992","unstructured":"Biller BM, Baum HB, Rosenthal DI, Saxe VC, Charpie PM, Klibanski A (1992) Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metabolism 75(3):692\u2013697. https:\/\/doi.org\/10.1210\/jcem.75.3.1517356","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1469_CR66","doi-asserted-by":"crossref","unstructured":"Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB et al (2008) Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom.;11(1):6\u201321. doi: 10.1016\/j.jocd.2007.12.002. PubMed PMID: 18442749","DOI":"10.1016\/j.jocd.2007.12.002"},{"key":"1469_CR67","doi-asserted-by":"publisher","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD et al (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65(2):265\u2013273. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02562.x. Epub 2006\/08\/05. PubMed PMID: 16886971","DOI":"10.1111\/j.1365-2265.2006.02562.x"},{"key":"1469_CR68","doi-asserted-by":"publisher","unstructured":"Honegger J, Nasi-Kordhishti I, Aboutaha N, Giese S (2020) Surgery for prolactinomas: a better choice? Pituitary.;23(1):45\u201351. https:\/\/doi.org\/10.1007\/s11102-019-01016-z. PubMed PMID: 31853793","DOI":"10.1007\/s11102-019-01016-z"},{"key":"1469_CR69","doi-asserted-by":"publisher","unstructured":"Corona G, Mannucci E, Jannini EA, Lotti F, Ricca V, Monami M et al (2009) Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction. J Sex Med.;6(5):1457-66. Epub 20090210. https:\/\/doi.org\/10.1111\/j.1743-6109.2008.01206.x. PubMed PMID: 19210705","DOI":"10.1111\/j.1743-6109.2008.01206.x"},{"key":"1469_CR70","doi-asserted-by":"publisher","unstructured":"Karaca Z, Unluhizarci K, Kelestimur F, Hypoprolactinemia (2023) Does it matter? Redefining the hypopituitarism and return from a mumpsimus: absence of proof is not the proof of absence. Rev Endocr Metab Disord. Epub 20231025 https:\/\/doi.org\/10.1007\/s11154-023-09847-9","DOI":"10.1007\/s11154-023-09847-9"},{"issue":"4","key":"1469_CR71","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/cen.14283","volume":"93","author":"R Krysiak","year":"2020","unstructured":"Krysiak R, Kowalcze K, Okopie\u0144 B (2020) Sexual function and depressive symptoms in young women with hypoprolactinaemia. Clin Endocrinol 93(4):482\u2013488","journal-title":"Clin Endocrinol"},{"issue":"5\u20136","key":"1469_CR72","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000527333","volume":"147","author":"R Krysiak","year":"2022","unstructured":"Krysiak R, Kowalcze K, Okopie\u0144 B (2022) Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic effects of Atorvastatin: a pilot study. Cardiology 147(5\u20136):497\u2013506 Epub 20221004. doi: 10.1159\/000527333. PubMed PMID: 36195057; PubMed Central PMCID: PMCPMC9808652","journal-title":"Cardiology"},{"issue":"3","key":"1469_CR73","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11102-024-01393-0","volume":"27","author":"I Uzun","year":"2024","unstructured":"Uzun I, Karaca Z, Hacio\u011flu A, Unluhizarci K, Kelestimur F (2024) The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions. Pituitary 27(3):277\u2013286. https:\/\/doi.org\/10.1007\/s11102-024-01393-0","journal-title":"Pituitary"},{"issue":"1","key":"1469_CR74","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C et al (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7\u201322 Epub 20231103. https:\/\/doi.org\/10.1007\/s11102-023-01360-1","journal-title":"Pituitary"},{"key":"1469_CR75","doi-asserted-by":"publisher","unstructured":"Mazziotti G, Doga M, Frara S, Maffezzoni F, Porcelli T, Cerri L et al (2016) Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine.;52(1):103\u2013\u200910. Epub 20151003. https:\/\/doi.org\/10.1007\/s12020-015-0738-z. PubMed PMID: 26433736","DOI":"10.1007\/s12020-015-0738-z"},{"issue":"1","key":"1469_CR76","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.beem.2017.03.002","volume":"31","author":"AM Formenti","year":"2017","unstructured":"Formenti AM, Maffezzoni F, Doga M, Mazziotti G, Giustina A (2017) Growth hormone deficiency in treated acromegaly and active Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab 31(1):79\u201390 Epub 20170309. https:\/\/doi.org\/10.1016\/j.beem.2017.03.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"1469_CR77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tem.2014.10.005","volume":"26","author":"G Mazziotti","year":"2015","unstructured":"Mazziotti G, Marzullo P, Doga M, Aimaretti G, Giustina A (2015) Growth hormone deficiency in treated acromegaly. Trends Endocrinol Metab 26(1):11\u201321 Epub 20141127. https:\/\/doi.org\/10.1016\/j.tem.2014.10.005","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"1469_CR78","doi-asserted-by":"publisher","first-page":"R231","DOI":"10.1530\/eje-17-0154","volume":"177","author":"G Mazziotti","year":"2017","unstructured":"Mazziotti G, Formenti AM, Frara S, Roca E, Mortini P, Berruti A et al (2017) MANAGEMENT OF ENDOCRINE DISEASE: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects. Eur J Endocrinol 177(5):R231\u2013r48 Epub 20170605. https:\/\/doi.org\/10.1530\/eje-17-0154","journal-title":"Eur J Endocrinol"},{"key":"1469_CR79","doi-asserted-by":"publisher","unstructured":"Formenti AM, Tecilazich F, Giubbini R, Giustina A (2019) Risk of vertebral fractures in hypoparathyroidism. Rev Endocr Metab Disord.;20(3):295\u2013302. https:\/\/doi.org\/10.1007\/s11154-019-09507-x. PubMed PMID: 31471845","DOI":"10.1007\/s11154-019-09507-x"},{"key":"1469_CR80","doi-asserted-by":"publisher","unstructured":"Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C et al (2020) A Consensus on the diagnosis and treatment of Acromegaly comorbidities: an update. J Clin Endocrinol Metab 105(4). https:\/\/doi.org\/10.1210\/clinem\/dgz096PubMed PMID: 31606735","DOI":"10.1210\/clinem\/dgz096"},{"key":"1469_CR81","doi-asserted-by":"publisher","unstructured":"Frara S, di Filippo L, Doga M, Loli P, Casanueva FF, Giustina A (2022) Novel approaches to bone comorbidity in Cushing\u2019s disease: an update. Pituitary.;25(5):754-9. Epub 20220718. https:\/\/doi.org\/10.1007\/s11102-022-01252-w. PubMed PMID: 35849272","DOI":"10.1007\/s11102-022-01252-w"},{"issue":"6","key":"1469_CR82","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3803\/EnM.2023.601","volume":"38","author":"A Giustina","year":"2023","unstructured":"Giustina A (2023) Acromegaly and bone: an update. Endocrinol Metab (Seoul) 38(6):655\u2013666 Epub 20231222. https:\/\/doi.org\/10.3803\/EnM.2023.601. PubMed PMID: 38164073; PubMed Central PMCID: PMCPMC10764988.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1469_CR83","doi-asserted-by":"publisher","unstructured":"Cianferotti L, Cipriani C, Corbetta S, Corona G, Defeudis G, Lania AG et al (2023) Bone quality in endocrine diseases: determinants and clinical relevance. J Endocrinol Invest.;46(7):1283\u2013\u2009304. Epub 20230314. https:\/\/doi.org\/10.1007\/s40618-023-02056-w. PubMed PMID: 36918505","DOI":"10.1007\/s40618-023-02056-w"},{"issue":"4","key":"1469_CR84","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41574-023-00942-0","volume":"20","author":"A Giustina","year":"2024","unstructured":"Giustina A, Lazaretti-Castro M, Martineau AR, Mason RS, Rosen CJ, Schoenmakers I (2024) A view on vitamin D: a pleiotropic factor? Nat Rev Endocrinol 20(4):202\u2013208 Epub 20240122. https:\/\/doi.org\/10.1038\/s41574-023-00942-0","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1469_CR85","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12020-022-03208-3","volume":"79","author":"A Giustina","year":"2023","unstructured":"Giustina A, Bouillon R, Dawson-Hughes B, Ebeling PR, Lazaretti-Castro M, Lips P et al (2023) Vitamin D in the older population: a consensus statement. Endocrine 79(1):31\u201344 Epub 20221026. https:\/\/doi.org\/10.1007\/s12020-022-03208-3","journal-title":"Endocrine"},{"key":"1469_CR86","doi-asserted-by":"publisher","unstructured":"di Filippo L, Bilezikian JP, Canalis E, Terenzi U, Giustina A (2024) New insights into the vitamin D\/PTH axis in endocrine-driven metabolic bone diseases. Endocrine. Epub 20240417. https:\/\/doi.org\/10.1007\/s12020-024-03784-6. PubMed PMID: 38632163","DOI":"10.1007\/s12020-024-03784-6"},{"key":"1469_CR87","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnae009","author":"A Giustina","year":"2024","unstructured":"Giustina A, Bilezikian JP, Adler RA, Banfi G, Bikle DD, Binkley NC et al (2024) Consensus Statement on vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows. Endocr Rev. Epub 20240427 https:\/\/doi.org\/10.1210\/endrev\/bnae009","journal-title":"Endocr Rev"},{"key":"1469_CR88","doi-asserted-by":"publisher","unstructured":"Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon R, Brannon PM et al (2018) Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. Br J Clin Pharmacol.;84(10):2194\u2013\u2009207. Epub 20180717. https:\/\/doi.org\/10.1111\/bcp.13652. PubMed PMID: 29851137; PubMed Central PMCID: PMCPMC6138489","DOI":"10.1111\/bcp.13652"},{"issue":"3","key":"1469_CR89","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11102-024-01398-9","volume":"27","author":"S Chiloiro","year":"2024","unstructured":"Chiloiro S, Giampietro A, Infante A, Mattogno PP, Lauretti L, Olivi A et al (2024) Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience. Pituitary 27(3):303\u2013309 Epub 20240507. https:\/\/doi.org\/10.1007\/s11102-024-01398-9","journal-title":"Pituitary"},{"key":"1469_CR90","doi-asserted-by":"publisher","unstructured":"Chiloiro S, Costanza F, Riccardi E, Giampietro A, De Marinis L, Bianchi A et al Vitamin D in pituitary driven osteopathies. Pituit 2024 Epub 20240824. https:\/\/doi.org\/10.1007\/s11102-024-01439-3. PubMed PMID: 39180644.","DOI":"10.1007\/s11102-024-01439-3"},{"issue":"1","key":"1469_CR91","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1210\/clinem\/dgab599","volume":"107","author":"L di Filippo","year":"2022","unstructured":"di Filippo L, Allora A, Doga M, Formenti AM, Locatelli M, Rovere Querini P et al (2022) Vitamin D levels are Associated with blood glucose and BMI in COVID-19 patients, Predicting Disease Severity. J Clin Endocrinol Metab 107(1):e348\u2013e60. https:\/\/doi.org\/10.1210\/clinem\/dgab599PubMed PMID: 34383926; PubMed Central PMCID: PMCPMC8385994","journal-title":"J Clin Endocrinol Metab"},{"key":"1469_CR92","doi-asserted-by":"publisher","unstructured":"Giustina A, Bouillon R, Binkley N, Sempos C, Adler RA, Bollerslev J et al (2020) Controversies in Vitamin D: A Statement From the Third International Conference. JBMR Plus.;4(12):e10417. Epub 20201110. https:\/\/doi.org\/10.1002\/jbm4.10417. PubMed PMID: 33354643; PubMed Central PMCID: PMCPMC7745884","DOI":"10.1002\/jbm4.10417"},{"key":"1469_CR93","doi-asserted-by":"publisher","unstructured":"Frara S, Uygur MM, Bolamperti F, di Filippo L, Doga M, Ferrari F et al (2024) High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma. Pituitary.;27(4):370\u2013\u200980. Epub 20240527. https:\/\/doi.org\/10.1007\/s11102-024-01394-z. PubMed PMID: 38802688","DOI":"10.1007\/s11102-024-01394-z"},{"issue":"4","key":"1469_CR94","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s11154-021-09693-7","volume":"22","author":"JP Bilezikian","year":"2021","unstructured":"Bilezikian JP, Formenti AM, Adler RA, Binkley N, Bouillon R, Lazaretti-Castro M et al (2021) Vitamin D: Dosing, levels, form, and route of administration: does one approach fit all? Rev Endocr Metab Disord 22(4):1201\u20131218 Epub 20211223. https:\/\/doi.org\/10.1007\/s11154-021-09693-7","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"1469_CR95","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s11154-023-09831-3","volume":"24","author":"A Giustina","year":"2023","unstructured":"Giustina A, di Filippo L, Facciorusso A, Adler RA, Binkley N, Bollerslev J et al (2023) Vitamin D status and supplementation before and after bariatric surgery: recommendations based on a systematic review and meta-analysis. Rev Endocr Metab Disord 24(6):1011\u20131029 Epub 20230904. https:\/\/doi.org\/10.1007\/s11154-023-09831-3","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"1469_CR96","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41584-024-01094-9","volume":"20","author":"NR Fuggle","year":"2024","unstructured":"Fuggle NR, Beaudart C, Bruy\u00e8re O, Abrahamsen B, Al-Daghri N, Burlet N et al (2024) Evidence-based Guideline for the management of osteoporosis in men. Nat Rev Rheumatol 20(4):241\u2013251. https:\/\/doi.org\/10.1038\/s41584-024-01094-9","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"1469_CR97","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an endocrine Society clinical practice guideline. J Clin Endocrinol Metabolism 104(5):1595\u20131622","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"1469_CR98","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ecl.2016","volume":"46","author":"A Cohen","year":"2017","unstructured":"Cohen A (2017) Premenopausal osteoporosis. Endocrinol Metab Clin North Am 46(1):117\u2013133 Epub 20161124. https:\/\/doi.org\/10.1016\/j.ecl.2016","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1469_CR99","doi-asserted-by":"publisher","unstructured":"Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD et al (2020) Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. J Clin Endocrinol Metab. Epub 20201026. https:\/\/doi.org\/10.1210\/clinem\/dgaa756. PubMed PMID: 33103722","DOI":"10.1210\/clinem\/dgaa756"},{"key":"1469_CR100","doi-asserted-by":"publisher","unstructured":"Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R (2020) Pharmacological management of osteoporosis in Postmenopausal women: an Endocrine Society Guideline Update. J Clin Endocrinol Metab 105(3). https:\/\/doi.org\/10.1210\/clinem\/dgaa048PubMed PMID: 32068863","DOI":"10.1210\/clinem\/dgaa048"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01469-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01469-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01469-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:38:45Z","timestamp":1733895525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01469-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1469"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01469-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"22 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.G. consultant for Abiogen and editor of Pituitary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}